文献速递心境障碍

Generation Scotland与荷兰双胞胎登记处抗抑郁药使用的全甲基化组关联研究提示固有免疫系统

Methylome-wide association study of antidepressant use in Generation Scotland and the Netherlands Twin Register implicates the innate immune system.
PubMed 文献 · Mol Psychiatry · 2021-12-08

在Generation Scotland(GS:SFHS,N=6428,EPIC芯片)与荷兰双胞胎登记处(NTR,N=2449,450K芯片)开展自我报告抗抑郁药使用的全甲基化组关联研究并做荟萃分析。GS:SFHS发现10个CpG位点与抗抑郁药使用显著关联,顶级位点位于ATP6V1B2基因内(β=-0.055,p校正=0.005);基于3799人训练的甲基化评分在3360人中预测抗抑郁药使用(β=0.377,p=3.12×10-11,R2=2.12%)。NTR未发现显著关联的CpG;荟萃分析识别出两个芯片共有的10个CpG中的2个与抗抑郁药使用显著关联,其中一个效应方向相反。

要点

  • GS:SFHS中10个CpG位点与自我报告抗抑郁药使用显著关联,顶级位点位于ATP6V1B2(β=-0.055,p校正=0.005)。
  • 其他位点注释至CASP10、TMBIM1、MAPKAPK3、HEBP2等既往与固有免疫应答相关的基因。
  • 基于3799人训练的甲基化评分在3360人中预测抗抑郁药使用(β=0.377,p=3.12×10-11,R2=2.12%)。

核心结论

  • 抗抑郁药与既往涉及精神健康障碍和固有免疫系统的位点表观遗传改变相关。
  • 这些改变在GS:SFHS一个亚组中预测自我报告的抗抑郁药使用,并识别出可能与临床相关抗抑郁药作用及副作用的机制理解有关的过程。

研究设计与样本

  • 在Generation Scotland(GS:SFHS,N=6428,EPIC芯片)和荷兰双胞胎登记处(NTR,N=2449,450K芯片)进行自我报告抗抑郁药使用的全甲基化组关联研究,并校正生活方式因素和MDD。
  • 对两个队列的抗抑郁药使用进行荟萃分析。
  • 使用惩罚回归在GS:SFHS的3799人亚组中训练基于甲基化的自我报告抗抑郁药使用评分,并在GS:SFHS第二个3360人亚组中验证。
  • 对处方选择性5-羟色胺再摄取抑制剂进行MWAS分析。

主要发现

  • GS:SFHS中发现10个CpG位点与自我报告抗抑郁药使用显著关联,顶级CpG位于ATP6V1B2基因内(β=-0.055,p校正=0.005)。
  • 其他顶级位点注释至CASP10、TMBIM1、MAPKAPK3和HEBP2等基因,这些基因既往与固有免疫应答相关。
  • 甲基化评分在GS:SFHS第二个亚组中预测抗抑郁药使用(N=3360,β=0.377,p=3.12×10-11,R2=2.12%)。
  • NTR中未发现任何CpG与抗抑郁药使用显著关联。
  • 荟萃分析识别出上述10个CpG中两个芯片共有的2个CpG与抗抑郁药使用显著关联,但其中一个的效应方向相反。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • NTR中未发现任何CpG与抗抑郁药使用显著关联。
  • 荟萃分析中两个芯片共有的2个CpG中一个效应方向相反。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antidepressants are an effective treatment for major depressive disorder (MDD), although individual response is unpredictable and highly variable. Whilst the mode of action of antidepressants is incompletely understood, many medications are associated with changes in DNA methylation in genes that are plausibly linked to their mechanisms. Studies of DNA methylation may therefore reveal the biological processes underpinning the efficacy and side effects of antidepressants. We performed a methylome-wide association study (MWAS) of self-reported antidepressant use accounting for lifestyle factors and MDD in Generation Scotland (GS:SFHS, N = 6428, EPIC array) and the Netherlands Twin Register (NTR, N = 2449, 450 K array) and ran a meta-analysis of antidepressant use across these two cohorts. We found ten CpG sites significantly associated with self-reported antidepressant use in GS:SFHS, with the top CpG located within a gene previously associated with mental health disorders, ATP6V1B2 (β = -0.055, pcorrected = 0.005). Other top loci were annotated to genes including CASP10, TMBIM1, MAPKAPK3, and HEBP2, which have previously been implicated in the innate immune response. Next, using penalised regression, we trained a methylation-based score of self-reported antidepressant use in a subset of 3799 GS:SFHS individuals that predicted antidepressant use in a second subset of GS:SFHS (N = 3360, β = 0.377, p = 3.12 × 10-11, R2 = 2.12%). In an MWAS analysis of prescribed selective serotonin reuptake inhibitors, we showed convergent findings with those based on self-report. In NTR, we did not find any CpGs significantly associated with antidepressant use. The meta-analysis identified the two CpGs of the ten above that were common to the two arrays used as being significantly associated with antidepressant use, although the effect was in the opposite direction for one of them. Antidepressants were associated with epigenetic alterations in loci previously associated with mental health disorders and the innate immune system. These changes predicted self-reported antidepressant use in a subset of GS:SFHS and identified processes that may be relevant to our mechanistic understanding of clinically relevant antidepressant drug actions and side effects.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Barbu MC, Huider F, Campbell A, et al. Methylome-wide association study of antidepressant use in Generation Scotland and the Netherlands Twin Register implicates the innate immune system. Mol Psychiatry. 2021. PMID: 34880450. doi:10.1038/s41380-021-01412-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。